Xenon Pharmaceuticals, Inc. (XENE)
53.84
+0.13
(+0.24%)
USD |
NASDAQ |
May 19, 13:57
Xenon Pharmaceuticals Research and Development Expense (Quarterly) : 87.92M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 7.47M |
| Alkermes Plc | 101.64M |
| Edesa Biotech, Inc. | 2.767M |
| ProMIS Neurosciences, Inc. | 6.971M |
| Tyra Biosciences, Inc. | 33.33M |